otosclerosis ent

42
OTOSCLEROSIS Salar Alam M10011 1

Upload: salar-alam

Post on 30-Jun-2015

1.696 views

Category:

Health & Medicine


3 download

DESCRIPTION

Undergraduate level presentation on Otosclerosis

TRANSCRIPT

Page 1: Otosclerosis ENT

1

OTOSCLEROSIS

Salar AlamM10011

Page 2: Otosclerosis ENT

2

Outline

•Related Anatomy•Pathogenesis•Clinical features•Diagnosis•Treatment•Complications

Page 3: Otosclerosis ENT

3

Related Anatomy

Page 4: Otosclerosis ENT

4

•Otic capsule▫The embryonic cartilage capsule that

surrounds the inner ear mechanism and develops into bony tissue.

•Otic labyrinth▫The endolymphatic labyrinth. Consists of

utricle, saccule, cochlea, Semicircular canals, endolymphatic duct and sac.

•Periotic labyrinth▫The perilymphatic labyrinth. Consists of

vestibule, scala vestibula, scala tympani and perilymphatic space around semicircular canals.

Page 5: Otosclerosis ENT

5

Page 6: Otosclerosis ENT

6

Membranous Labyrinth

Page 7: Otosclerosis ENT

7

Page 8: Otosclerosis ENT

8

Otosclerosis

A primary disease of the bony otic capsule characterized by abnormal

removal of mature bone by osteoclasts and replacement with woven bone of

greater thickness, cellularity and vascularity.

Page 9: Otosclerosis ENT

9

•Autosomal-dominant hereditary disease•Leads to progressive conducting hearing

loss•Most common cause of CHL in adults•Bilateral hearing loss in 70% cases•Male:Female is 1:2•Most commonly effected age group is 15-45

years old with hearing loss manifesting typically in the third decade

•Cochlear otosclerosis manifests with sensorineural hearing loss

Page 10: Otosclerosis ENT

10

Etiology

•The exact cause is unknown but many factors have been proposed such as:▫Hereditary▫Endocrine (pregnancy)▫Trauma▫Infectious (eg: measles)▫Vascular▫Autoimmune

Page 11: Otosclerosis ENT

11

Pathogenesis

Page 12: Otosclerosis ENT

12

•Divided in two phases:▫Early spongiotic phase (otospongiosis)

Osteocytes, histiocytes, osteoclasts Active reabsorption of bone Stains blue (blue mantles) on using H&E stain Dilated vessels (Schwartze’s sign)

▫Late or Sclerotic phase Formation of new bone in resorption areas New bone is dense and sclerotic Stains red on using H&E stain Starts in endochondral bone then involves

endosteal & periosteal layers and membranous labyrinth as disease progress

Page 13: Otosclerosis ENT

13

Histopathology

Histologic otosclerosis with small focus in the anterior oval window (arrow).

Clinical otosclerosis. The lesion has spread across the annular ligament and fixed the stapes.

Page 14: Otosclerosis ENT

14

Types of Stapedial fixation• Anterior Focus

▫ Most common, at fissula ante fenestram

• Posterior Focus▫ Lesion spreading from posterior oval window to annular

ligament

• Circumferential▫ Lesion flows across the ligament totally obliterating the

annular ligament

• Biscuit type▫ Lesion replacing entire footplate, but no involvement of

annular ligament leading to a solid footplate

• Obliterative▫ Completely obliterates the oval window

Page 15: Otosclerosis ENT

15

•Other areas are:▫Round window, the apex of the cochlea, the

cochlear aqueduct, the semicircular canals, and the stapes footplate itself

Page 16: Otosclerosis ENT

16

Hearing Loss•Conducting Hearing Loss (CHL)

▫Stapedial fixation

•Sensorineural Hearing Loss (SNHL)▫Cochlear otosclerosis

•Mixed

Page 17: Otosclerosis ENT

17

Diagnosis

Page 18: Otosclerosis ENT

18

History

•Gradual onset of hearing loss progressing slowly

• In 70% cases hearing loss is bilateral•Usually becomes apparent around the age of

30•Loss noticeable when it reaches 25 to 30 dB•Paracusis of Willis (characteristic of CHL)•Unilateral loss noticed even later, problem

with localization of sound•Tinnitus•Positive family history

Page 19: Otosclerosis ENT

19

Physical Examination•Otoscopy

Schwartze sign; red blush occasionally seen over promontory or anterior to oval window

• Pneumo-otoscopy used to rule out other causes of CHL such as middle ear serous fluid or small perforation

• Tuning Fork Test▫ Weber Test▫ Rinne Test

Page 20: Otosclerosis ENT

20

•Weber test▫Performed with 512 Hz tuning fork▫Lateralizes to ear with conductive or

greater conductive loss▫Lateralizes with 5 dB of conductive hearing

loss

Page 21: Otosclerosis ENT

21

•Rinne test▫Performed with 512 or 1024 Hz tuning

forks▫Compares patient perception of loudness of

air conduction versus bone conduction▫If BC > AC on 512 Hz fork

Loss is 15 – 20 dB▫If BC > AC on 1024 Hz fork

Loss is at least 30 db

Page 22: Otosclerosis ENT

22

Audiometry•Pure Tone Audiometry

▫Loss of air conduction at lower frequencies

▫Bone conduction normal, sometimes shows a dip at 2000 Hz (Cahart’s notch) which disappears after successful surgery.

•Speech Audiometry▫Normal except in those

with cochlear involvement.

Page 23: Otosclerosis ENT

23

•Impedance Audiometry▫ Tympanometry : As type curve

Page 24: Otosclerosis ENT

24

•Acoustic reflex▫Measure of movement of stapes at stimulus▫Reflex is absent in otosclerosis

Progressive changes in the configuration of the acoustic reflex with stapedial fixation. A, healthy reflex with a sustained change in compliance as long as stimulus is on. B, diphasic reflex with on-off pattern. Seen in cases of early otosclerotic fixation. C, Absent acoustic reflex

Page 25: Otosclerosis ENT

25

Radiological Investigations

•High resolution CT scan▫Shows subtle areas of demineralisation▫In case of cochlear involvement it shows

“double ring sign”•MRI

▫Done for patients with unusual presentation

▫Detects congenital anomalies of cochlea▫Excludes retrocochlear pathology eg.

Acoustic neuroma

Page 26: Otosclerosis ENT

26

Treatment

Page 27: Otosclerosis ENT

27

Treatment Options

•Hearing aid

•Surgical management

•Observation

•Medical management

Page 28: Otosclerosis ENT

28

Medical management

•Aim is to Stabilize the disease by reduction of the osteoclastic bone resorption

increase osteoblastic bone formation Inhibits proteolytic enzymes that are cytotoxic

to cochlea.• Slows the progression of sensorineural

hearing loss• Not commonly used

Page 29: Otosclerosis ENT

29

•Sodium Fluoride therapy Contraindicated in patients with

Chronic nephritis Chronic rheumatoid arthritis Pregnant and lactating women Children

• Bisphosphonates

Page 30: Otosclerosis ENT

30

Hearing Aid

•Very effective in early stage of disease•But can be used in advance stage, if: Surgery is contraindicated Patient refuses the surgery In far-advance cases it is required, even

after stapedotomy

Page 31: Otosclerosis ENT

31

Surgical Management

•Poorer ear always chosen for surgery•Done preferably under local anesthesia so

patient can notify surgeon if vertigo occurs during procedure

•Options are: Stapedotomy Stapedectomy

• Lesser complications due to use of Lasers now.

Page 32: Otosclerosis ENT

32

Selection Criteria

•Hearing threshold is 30dB or worse

•AB gap at least 15dB

•Rinne’s negative for 256 Hz and 512 Hz

•Speech Discrimination Score is 60% or

more

Page 33: Otosclerosis ENT

33

Prosthesis Teflon piston

Stainless steel piston

Platinum Teflon piston

Titanium Teflon piston

Page 34: Otosclerosis ENT

34

Summary of small fenestra stapedotomy• Anethesia injected

• Incisions at lateral process of malleus and inferiorly

• Tympanomeatal flap elevated

• Adequate exposure (facial nerve superiorly, pyramidal process

inferiorly)

• Distance from incus to footplate measured (usu. 4.5mm)

• Microdrill used to create fenestra

• Prosthesis placed on incus and crimped firmly in place.

• Incudostapedial joint separated and stapedial tendon sectioned

• Stapes superstructure fractured and removed

• Prosthesis checked

• Tympanomeatal flap returned to normal position

Page 35: Otosclerosis ENT

35

Stapedotomy v/s Stapedectomy

•StapedotomyoSaferoLower rate of high frequency

sensorineural hearing loss post op.

•StapedectomyoLess chances of recurrence

Page 36: Otosclerosis ENT

36

Postoperative Care

•Patient’s head elevated to 30o to reduce perilymph pressure in vestibule

•Bed rest for at least 1 hour•If no vertigo on getting up then patient

can go home•Patients can resume air travel after 5 days•Follow up with audiogram in 3 weeks

Page 37: Otosclerosis ENT

37

Contraindications •Only hearing ear•Meniere’s disease•Occupation Experience frequent change in pressure Works in noisy surrounding

• Otitis externa• Perforated TM• Young children• Poor state of health

Page 38: Otosclerosis ENT

38

Complications

Page 39: Otosclerosis ENT

39

Intra-Operative Complications

• Exposed, overhanging Facial Nerve (9%)

• Chorda tympani nerve damage (30%)

• Solid or Obliterated Footplate

• Floating Footplate

• Persistent Stapedial Artery

• Perilymph Gusher

Managed by placing tissue graft over oval window

• Tympanic Membrane perforation

• Intraoperative vertigo due to long prosthesis

• Fixed Malleus

Page 40: Otosclerosis ENT

40

Post-Operative Complications

• SNHL

• Vertigo

• Facial paralysis

• Tinnitus

• Taste disturbance

• Perilymph fistula

• Dead ear (1%)

• Iatrogenic tympanic membrane perforation

Page 41: Otosclerosis ENT

41

References• Cummings Otolaryngology - edited by Paul W. Flint, Bruce

H. Haughey, Valerie J. Lund, John K. Niparko, Mark A. Richardson, K. Thomas Robbins, and J. Regan Thomas

• Current Diagnosis & Treatment in Otolaryngology - Head & Neck Surgery 

Page 42: Otosclerosis ENT

42

THANK YOU